Dasatinib Interactions
There are 816 drugs known to interact with dasatinib, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 245 are major, 552 are moderate, and 19 are minor.
- View all 816 medications that may interact with dasatinib
- View dasatinib alcohol/food interactions (1)
- View dasatinib disease interactions (6)
Most frequently checked interactions
View interaction reports for dasatinib and the medicines listed below.
- Dextrose (glucose)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Ginkgo Biloba (ginkgo)
- Ginkgo Biloba (ginkgo)
- Jardiance (empagliflozin)
- Jardiance (empagliflozin)
- Keppra (levetiracetam)
- Keppra (levetiracetam)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Topamax (topiramate)
- Topamax (topiramate)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
Dasatinib alcohol/food interactions
There is 1 alcohol/food interaction with dasatinib.
Dasatinib disease interactions
There are 6 disease interactions with dasatinib which include:
- cardiovascular disease
- fluid retention
- bone marrow suppression
- hepatic impairment
- pulmonary arterial hypertension
- QT prolongation
Report options
More about dasatinib
- dasatinib consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (27)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
